Purple Biotech
PPBT
10 hedge funds and large institutions have $4.09M invested in Purple Biotech in 2021 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 4 reducing their positions, and 2 closing their positions.
13% more call options, than puts
Call options by funds: $793K | Put options by funds: $702K
0% less ownership
Funds ownership: 0% → 0% (-0%)
9% less funds holding
Funds holding: 11 → 10 (-1)
22% less capital invested
Capital invested by funds: $5.27M → $4.09M (-$1.18M)
50% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 2
75% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$147K |
| 2 |
VVP
Venture Visionary Partners
Sylvania,
Ohio
|
+$4.26K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AIM
ARK Investment Management
St. Petersburg,
Florida
|
-$313K |
| 2 |
Group One Trading
Chicago,
Illinois
|
-$165K |
| 3 |
CCM
Condor Capital Management
Martinsville,
New Jersey
|
-$96K |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$4.26K |
| 5 |
Morgan Stanley
New York
|
-$852 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
AIM
1
ARK Investment Management
St. Petersburg,
Florida
| $2.58M | -$313K | -368 | -10% |
|
2
Point72 Asset Management
Stamford,
Connecticut
| $1.09M | – | – | – |
|
|
3
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $134K | +$147K | +172 | New |
|
|
4
Morgan Stanley
New York
| $91K | -$852 | -1 | -0.8% |
|
|
WTB
5
Washington Trust Bank
Spokane,
Washington
| $64K | – | – | – |
|
6
Geode Capital Management
Boston,
Massachusetts
| $49K | – | – | – |
|
|
VVP
7
Venture Visionary Partners
Sylvania,
Ohio
| $43K | +$4.26K | +5 | +10% |
|
|
8
Group One Trading
Chicago,
Illinois
| $31K | -$165K | -194 | -83% |
|
|
9
UBS Group
Zurich,
Switzerland
| $12K | -$4.26K | -5 | -25% |
|
|
NSIM
10
North Star Investment Management
Chicago,
Illinois
| $1K | – | – | – |
|
|
CCM
11
Condor Capital Management
Martinsville,
New Jersey
| – | -$96K | -105 | Closed |
|
PPBT Hedge Fund Activity: Q4 2021 in Review
10 of the 6,499 institutional investors tracked by Wall St. Rank reported a position in Purple Biotech (PPBT) for Q4 2021, worth a combined $4.09M — down 22% from $5.27M a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of PPBT and 1 opened new positions — a net loss of 1 holder — while 4 trimmed existing stakes and 1 added.
The largest buyer was Susquehanna International Group, opening a new position worth an estimated $147K. The largest seller was ARK Investment Management, cutting an estimated $313K.
- 10 institutional investors held Purple Biotech (PPBT) as of Q4 2021, down from 11 in Q3 2021.
- Funds reported $4.09M of Purple Biotech stock for Q4 2021, down 22% quarter-over-quarter.
- 1 fund opened new Purple Biotech positions in Q4 2021 and 2 closed out, a net change of -1 holder.
- The largest Purple Biotech buyer in Q4 2021 was Susquehanna International Group, an estimated $147K added.
- The largest Purple Biotech seller in Q4 2021 was ARK Investment Management, an estimated $313K sold.
Based on aggregated 13F filings for Q4 2021.